Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,560	2,357	1,588	3,178	1,001	475
Market Cap Growth	2.59%	48.44%	-50.04%	217.33%	110.87%	222.46%
Enterprise Value	1,264	2,057	1,374	3,092	970	457
Last Close Price	12.35	18.61	12.50	24.97	7.95	3.77
PE Ratio	53.07	77.43	11.18	20.23	5442.54	-
Forward PE	131.33	55.42	19.45	32.20	-	-
PS Ratio	24.13	36.46	7.32	13.70	64.96	148.54
PB Ratio	4.61	6.96	4.36	15.49	24.08	12.10
P/TBV Ratio	4.61	6.96	4.36	15.49	24.08	12.10
P/FCF Ratio	12.44	18.80	-	17.19	279.73	-
P/OCF Ratio	12.44	18.79	-	17.18	278.25	-
EV/Sales Ratio	19.55	31.82	6.34	13.33	62.94	142.84
EV/EBITDA Ratio	57.29	93.25	7.67	15.52	-	-
EV/EBIT Ratio	57.35	93.35	7.67	15.52	-	-
EV/FCF Ratio	10.08	16.41	-	16.73	271.04	-
Net Debt / Equity Ratio	-0.87	-0.87	-0.61	-1.11	-0.97	-0.94
Net Debt / EBITDA Ratio	-13.42	-13.42	-1.24	-1.15	55.65	4.47
Net Debt / FCF Ratio	-2.36	-2.36	19.70	-1.24	-11.22	3.69
Asset Turnover	0.17	0.17	0.66	1.59	0.37	0.10
Quick Ratio	74.40	74.40	8.69	5.68	24.59	47.58
Current Ratio	76.60	76.60	8.73	5.78	25.77	49.87
Return on Equity (ROE)	8.67%	8.67%	49.92%	127.30%	0.46%	-24.57%
Return on Assets (ROA)	3.66%	3.66%	34.05%	85.52%	-1.10%	-15.83%
Return on Invested Capital (ROIC)	40.70%	18.73%	235.12%	-	-37.74%	-663.42%
Return on Capital Employed (ROCE)	6.50%	6.50%	49.20%	97.10%	-1.80%	-21.00%
Earnings Yield	1.95%	1.29%	8.95%	4.94%	0.02%	-1.64%
FCF Yield	8.04%	5.32%	-0.71%	5.82%	0.36%	-2.10%
Buyback Yield / Dilution	0.01%	0.01%	-0.01%	-1.44%	-8.76%	-10.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.